FDA panel to review Novavax vaccine as potential fourth shot for adult Americans, and Pete Buttigieg tests positive for COVID

An advisory panel to the U.S. Food and Drug Administration is due to meet later Tuesday to review the vaccine developed by Novavax Inc. as a potential fourth shot for American adults and will vote on whether the risks outweigh the benefits.